|
Indian Pediatr 2018;55: 352 |
|
Clippings
Theme: General Pediatrics
|
K Rajeshwari
Email:
[email protected]
|
|
Pediatric Teledermatology (JAMA Dermatol. 2017;153:1243-8)
|
Advances in smartphone photography (both quality and image transmission)
may improve access to care via direct parent-to-clinician telemedicine.
However, the accuracy of diagnoses that are reliant on parent-provided
photographs has not been formally compared with diagnoses made in
person. This study assessed whether smartphone photographs of pediatric
skin conditions taken by parents are of sufficient quality to permit
accurate diagnosis. Forty patient-parent dyads at a pediatric dermatology
clinic at the Children’s Hospital of Philadelphia were enrolled to
assess concordance between diagnoses made by an independent pediatric
dermatologist based on in-person examination and those based on parental
photographs. Half of the patient-parent dyads were randomized for a
secondary analysis to receive instructions on how best to take
photographs with smartphones. Clinicians were blinded to whether parents
had received photography instructions. Half of the patient-parent dyads
received a simple, 3-step instruction sheet on how best to take
photographs using a smartphone (intervention group); the other half did
not (control group).Among the 40 patient-parent dyads, overall
concordance between photograph-based versus in-person diagnosis was 83%.
There was no statistically significant effect of photography
instructions on concordance.
In this era, smartphone photography by parents can
accurately be used as a method to provide pediatric dermatologic care.
This is especially useful if the patient lives far away and cannot reach
a dermatologist soon.
|
|
Dexlanzoprazole for gastroesophageal reflux disease (Dig
Dis Sci. 2017;62:3059-68)
|
Proton pump inhibitors are commonly used to treat gastro-esophageal
reûux disease (GERD) and nonerosive GERD (NERD) in adolescents and
adults. Despite the efficacy of available medications, many patients
have persisting symptoms, indicating a need for more effective drugs.
This phase-2, open-label, multicenter study aimed to assess the efficacy
of dexlansoprazole delayed-release capsules in adolescents (age 12-17 y)
for treatment of symptomatic NERD. Adolescents with endoscopically
conûrmed NERD received a daily dose of 30 mg dexlansoprazole for 4
weeks. The primary end point was treatment emergent adverse events
experienced by patients. Heartburn symptoms and severity were recorded
daily in patient electronic diaries and independently assessed by the
investigator, along with patient-reported quality of life, at the
beginning and end of the study. Diarrhea and headache were the only
adverse effects reported by patients. Dexlansoprazole-treated patients
reported a median 47.3% of days with neither daytime nor nighttime
heartburn. Symptoms such as epigastric pain, acid regurgitation, and
heartburn improved in severity for 73-80% of patients.
Authors concluded that 30 mg dexlansoprazole in adolescent NERD is
generally well tolerated and had beneficial effects on improving
heartburn symptoms and quality of life.
|
|
Ondansetron for Rotavirus diarrhea (PLoS One.
2017;12:e0186824)
|
Rotavirus and norovirus cause acute gastroenteritis with severe diarrhea
and vomiting, symptoms that may lead to severe dehydration and death.
The objective of this randomized double-blinded placebo-controlled study
was to investigate whether ondansetron, a serotonin receptor antagonist,
could attenuate rotavirus- and norovirus-induced vomiting and diarrhea,
which would facilitate oral rehydration and reduce need for
hospitalization. Children (age 6 mo to 16 y) with acute gastroenteritis
were enrolled (n=104) and randomized to one single oral dose
(0.15 mg/kg) of ondansetron orplacebo. The number of diarrhea and
vomiting episodes during the 24 hours following treatment was reported
as well as the number of days with symptoms. Pathogens in faeces were
diagnosed by real-time PCR. Outcome parameters were analyzed for
rotavirus- and noroviruspositive children.
One dose of oral ondansetron reduced duration of
rotavirus clinical symptoms with a median of two days. Furthermore,
ondansetron reduced diarrhea episodes, most pronounced in children who
had been sick for more than 3 days before treatment. Authors concluded
that Ondansetron may be a beneficial treatment for children with
rotavirus gastroenteritis.
|
|
Biomarkers of e-waste pollution (Environ Int.
2018;115:117-26)
|
Air pollution is a risk factor for cardiovascular disease (CVD), and
cardiovascular changes in childhood may contribute to the development
and progression of cardiovascular illnesses later in life. The aim of
this study was to investigate the effect of air pollutant exposure on
the child sympatho-adrenomedullary (SAM) system, which plays a vital
role in controlling the cardiovascular system. Two plasma biomarkers
(plasma epinephrine and norepinephrine) of SAM activity and heart rate
were measured in preschool children living in Guiyu, China. Air
pollution data, over the 4-months before the health examination, was
also collected. Environmental PM2.5, PM10, SO2, NO2 and CO, plasma norepinephrine and heart rate of the e-waste recycling area were
significantly higher than for the non-e-waste recycling area. PM2.5,
PM10, SO2 and NO2 data, over the 30-day and the 4-month average of
pollution before the health examination, showed a positive association
with plasma norepinephrine level. At the same time, plasma
norepinephrine and heart rate on children in the high air pollution
level group ( £50
m radius of family-run workshops) were higher than those in the low air
pollution level group.
These results suggest that air pollution exposure in e-waste
recycling areas could result in an increase in heart rate and plasma
norepinephrine, implying that e-waste air pollutant exposure impairs the
sympatho-adrenomeduallary system in children.
|
|
|
|